3,6,9,12-Tetraoxatetradecansaeure | 5650-19-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 3,6,9,12-Tetraoxatetradecansaeure
• 英文别名: 2-[2-[2-(2-Ethoxyethoxy)ethoxy]ethoxy]acetic acid
• CAS: 5650-19-1
• 化学式: C₁₀H₂₀O₆
• 分子量: 236.265
• InChiKey: XJGUMLITIZHCGE-UHFFFAOYSA-N

物化性质

• 沸点：
  352.3±27.0 °C(Predicted)
• 密度：
  1.105±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  16
• 可旋转键数：
  12
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  74.2
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  3,6,9,12-Tetraoxatetradecansaeure 在 吡啶 、 五氯化磷 作用下， 以 氯仿 为溶剂， 反应 50.0h， 生成 2-Benzyloxy-3-(3,6,9-trioxadecanoyloxy)propyl-3,6,9,12-tetraoxatetradecanoat
  参考文献：
  名称：

  Heimann, Ulrich; Voegtle, Fritz, Liebigs Annalen der Chemie, 1980, # 6, p. 858 - 862

  摘要：

  DOI：
• 作为产物：
  描述：

  1-(2-氯乙氧基)-2-乙氧基乙烷 在 氢氧化钾 、 potassium permanganate 、 sodium 作用下， 以 水 为溶剂， 反应 14.0h， 生成 3,6,9,12-Tetraoxatetradecansaeure
  参考文献：
  名称：

  Heimann, Ulrich; Voegtle, Fritz, Liebigs Annalen der Chemie, 1980, # 6, p. 858 - 862

  摘要：

  DOI：

文献信息

• [EN] PHENYLNAPHTHYLIMIDAZOLES FOR USE ON COPPER SURFACES DURING SOLDERING<br/>[FR] PHÉNYLNAPHTHYLIMIDAZOLES EN VUE D'UNE UTILISATION SUR LES SURFACES EN CUIVRE AU COURS D'UN BRASAGE
  申请人：SHIKOKU CHEM

  公开号：WO2005121101A1

  公开（公告）日：2005-12-22

  A surface treating agent containing a novel phenylnaphthylimidazole compound represented by the following formula is brought into contact with the surface of copper or a copper alloy. In the formula, when A1 is a phenyl group, then A2 represents a 1-naphthyl group or a 2-naphthyl group, and when A1 is a 1-naphthyl group or a 2-naphthyl group, then A2 represents a phenyl group; and R represents a hydrogen atom or a methyl group.

  含有所述下列公式表示的新型苯基萘基咪唑啉化合物的表面处理剂与铜或铜合金的表面接触。在公式中，当A1是苯基时，A2代表1-萘基或2-萘基，当A1是1-萘基或2-萘基时，A2代表苯基；R代表氢原子或甲基。
• Antithrombotic compound
  申请人：Sanofi-Aventis

  公开号：EP1574516A1

  公开（公告）日：2005-09-14

  The present invention relates compounds of the formula A         oligosaccharide-spacer-GpIIb/IIIa antagonist     (A), wherein the oligosaccharide is a negatively charged oligosaccharide residue comprising four to twenty five monosaccharide units, the charge being compensated by positively charged counterions, and wherein the oligosaccharide residue is derived from an oligosaccharide which has (AT-III mediated) anti-Xa activity per se; the spacer is a bond or an essentially pharmacologically inactive linking residue; the GpIIb/IIIa antagonist is a residue mimicking the RGD and/or K(QA)GD fragment of fibrinogen, typically comprising an optionally esterified carboxylate moiety and a basic moiety located within the residue at a distance of 10-20 Å from each other; or a pharmaceutically acceptable salt thereof or a prodrug or a solvate thereof. The compounds of the invention have antithrombotic activity and can be used in treating or preventing thrombotic diseases.

  本发明涉及以下公式A的化合物 寡糖-间隔-GpIIb/IIIa拮抗剂（A）， 其中 寡糖是由四到二十五个单糖单位组成的带负电的寡糖残基，其电荷由带正电的对离子补偿，寡糖残基来源于具有（AT-III介导的）抗Xa活性的寡糖； 间隔是一种键或基本上是药理学上不活性的连接残基； GpIIb/IIIa拮抗剂是模拟纤维蛋白原的RGD和/或K(QA)GD片段的残基，通常包括一个可选择酯化的羧酸基团和一个位于残基内距离为10-20埃的基本基团； 或其药学上可接受的盐或其前药或其溶剂化物。 本发明的化合物具有抗血栓活性，可用于治疗或预防血栓性疾病。
• Synthesis and Antitumor Activity of 9-Acyloxyellipticines.
  作者：Naoyuki HARADA、Kunihiko OZAKI、Kouji ODA、Noriyuki NAKANISHI、Motoaki OHASHI、Tomiki HASHIYAMA、Kenji TSUJIHARA

  DOI：10.1248/cpb.45.1156

  日期：——

  Various kinds of water-soluble 9-acyloxyellipticine derivatives were synthesized in a search for compounds with potent antitumor activity. Antitumor activities against several tumors in mice (P388 leukemia, colon 26, Lewis lung carcinoma and B16 melanoma) were evaluated by using intravenous administration. Many compounds exhibited good antitumor activities; in particular, the glutarate derivative (5o) showed potent antitumor activity. This comopound (5o) may be converted to 9-hydroxyellipticine (2) by enzyme-catalyzed hydrolysis in the body.

  合成了多种水溶性9-酰氧基椭圆碱衍生物，以寻找具有强抗肿瘤活性的化合物。通过静脉给药评估了对小鼠几种肿瘤（P388白血病、结肠26、刘易斯肺癌和B16黑色素瘤）的抗肿瘤活性。许多化合物表现出良好的抗肿瘤活性；特别是戊二酸衍生物（5o）显示出强的抗肿瘤活性。该化合物（5o）可能通过体内酶催化的水解转化为9-羟基椭圆碱（2）。
• Phenylnaphthylimidazole Compound and Usage of the Same
  申请人：Hirao Hirohiko

  公开号：US20070246134A1

  公开（公告）日：2007-10-25

  A surface treating agent containing a novel phenylnaphthylimidazole compound represented by the following formula is brought into contact with the surface of copper or a copper alloy. In the formula, when A 1 is a phenyl group, then A 2 represents a 1-naphthyl group or a 2-naphthyl group, and when A 1 is a 1-naphthyl group or a 2-naphthyl group, then A 2 represents a phenyl group; and R represents a hydrogen atom or a methyl group.

  一种表面处理剂，其含有一种新的苯基萘亚咪唑化合物，其化学式如下，与铜或铜合金的表面接触。在该式中，当A1为苯基时，A2表示1-萘基或2-萘基，当A1为1-萘基或2-萘基时，A2表示苯基；R表示氢原子或甲基基团。
• ANTITHROMBOTIC COMPOUND
  申请人：BUIJSMAN Christian Rogier

  公开号：US20070293442A1

  公开（公告）日：2007-12-20

  The present invention relates compounds of the formula A oligosaccharide-spacer-GpIIb/IIIa antagonist   (A). The compounds of the invention have antithrombotic activity and can be used in treating or preventing thrombotic diseases.

  本发明涉及公式A寡糖-间隔物-GpIIb/IIIa拮抗剂的化合物。本发明的化合物具有抗血栓活性，并可用于治疗或预防血栓性疾病。